BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32699085)

  • 1. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
    Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
    Mladinich MC; Schwedes J; Mackow ER
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells.
    Mladinich MC; Conde JN; Schutt WR; Sohn SY; Mackow ER
    mBio; 2021 Aug; 12(4):e0196221. PubMed ID: 34399621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.
    Miorin L; Laurent-Rolle M; Pisanelli G; Co PH; Albrecht RA; García-Sastre A; Morrison J
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS5-independent Ablation of STAT2 by Zika virus to antagonize interferon signalling.
    Shu J; Ma X; Zhang Y; Zou J; Yuan Z; Yi Z
    Emerg Microbes Infect; 2021 Dec; 10(1):1609-1625. PubMed ID: 34340648
    [No Abstract]   [Full Text] [Related]  

  • 6. SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication.
    Su CI; Tseng CH; Yu CY; Lai MMC
    J Virol; 2016 May; 90(9):4308-4319. PubMed ID: 26889037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.
    Grant A; Ponia SS; Tripathi S; Balasubramaniam V; Miorin L; Sourisseau M; Schwarz MC; Sánchez-Seco MP; Evans MJ; Best SM; García-Sastre A
    Cell Host Microbe; 2016 Jun; 19(6):882-90. PubMed ID: 27212660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SUMO Modification of the Non-Structural Protein 5 of Zika Virus as a Host-Targeting Antiviral Strategy.
    Zhu Z; Chu H; Wen L; Yuan S; Chik KK; Yuen TT; Yip CC; Wang D; Zhou J; Yin F; Jin DY; Kok KH; Yuen KY; Chan JF
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zika Virus NS5 Forms Supramolecular Nuclear Bodies That Sequester Importin-α and Modulate the Host Immune and Pro-Inflammatory Response in Neuronal Cells.
    Ng IHW; Chan KW; Tan MJA; Gwee CP; Smith KM; Jeffress SJ; Saw WG; Swarbrick CMD; Watanabe S; Jans DA; Grüber G; Forwood JK; Vasudevan SG
    ACS Infect Dis; 2019 Jun; 5(6):932-948. PubMed ID: 30848123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear localization of Zika virus NS5 contributes to suppression of type I interferon production and response.
    Zhao Z; Tao M; Han W; Fan Z; Imran M; Cao S; Ye J
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 31859616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
    Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.
    Chaudhary V; Yuen KS; Chan JF; Chan CP; Wang PH; Cai JP; Zhang S; Liang M; Kok KH; Chan CP; Yuen KY; Jin DY
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue Non-structural Protein 5 Polymerase Complexes With Promyelocytic Leukemia Protein (PML) Isoforms III and IV to Disrupt PML-Nuclear Bodies in Infected Cells.
    Giovannoni F; Ladelfa MF; Monte M; Jans DA; Hemmerich P; García C
    Front Cell Infect Microbiol; 2019; 9():284. PubMed ID: 31456950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.
    El Sahili A; Soh TS; Schiltz J; Gharbi-Ayachi A; Seh CC; Shi PY; Lim SP; Lescar J
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis and insight into Zika virus NS5 mediated interferon inhibition.
    Dar HA; Zaheer T; Paracha RZ; Ali A
    Infect Genet Evol; 2017 Jul; 51():143-152. PubMed ID: 28365387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
    Patra U; Müller S
    Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I Signaling.
    Li A; Wang W; Wang Y; Chen K; Xiao F; Hu D; Hui L; Liu W; Feng Y; Li G; Tan Q; Liu Y; Wu K; Wu J
    Front Immunol; 2020; 11():51. PubMed ID: 32117232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.